SiteOne Therapeutics: Funding, Investors & Team (Oct 2026)
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.
SiteOne Therapeutics has raised $115M across 2 funding rounds on record, the most recent a Series C of $100M announced in Dec 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SiteOne Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2024.
SiteOne Therapeutics Funding Rounds
SiteOne Therapeutics raised $15.0M in an undisclosed round announced in May 2023.
1.6 years later, a Series C of $100M was announced in Dec 2024.
SiteOne Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
SiteOne Therapeutics Funding Compared to Other Biotechnology Startups
SiteOne Therapeutics' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SiteOne Therapeutics in Biotechnology and Bozeman
Companies Similar to SiteOne Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
SiteOne Therapeutics Funding FAQs
What does SiteOne Therapeutics do?
SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.
How much funding has SiteOne Therapeutics raised?
SiteOne Therapeutics has raised $115M across 2 rounds on record. The most recent is a Series C of $100M announced in Dec 2024.
When did SiteOne Therapeutics last raise funding?
SiteOne Therapeutics' most recent funding round on record is a Series C of $100M, announced in Dec 2024.
Who founded SiteOne Therapeutics?
FundedIQ lists George Miljanich (Founder) at SiteOne Therapeutics.
Where is SiteOne Therapeutics headquartered?
SiteOne Therapeutics is based in Bozeman, Montana, United States.
How many employees does SiteOne Therapeutics have?
SiteOne Therapeutics is in the 11-50 employee band.
How does SiteOne Therapeutics' funding compare to other Biotechnology startups?
SiteOne Therapeutics' latest round of $100M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SiteOne Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SiteOne Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.